107
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Safety and Efficacy of Partial Omentectomy in Laparoscopic Distal Gastrectomy for pT3-T4a Stage Gastric Cancer

, , & ORCID Icon
Pages 4681-4690 | Received 20 Aug 2023, Accepted 06 Oct 2023, Published online: 17 Oct 2023

References

  • Kurokawa Y, Doki Y, Mizusawa J, et al. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a Phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol. 2018;3(7):460–468. doi:10.1016/S2468-1253(18)30090-6
  • Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1–21. doi:10.1007/s10120-020-01042-y
  • Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1–25. doi:10.1007/s10120-022-01331-8
  • Lin HW, Loh EW, Shen SC, Tam KW. Gastrectomy with or without omentectomy for gastric cancer: a systematic review and meta-analysis. Surgery. 2022;171(5):1281–1289. doi:10.1016/j.surg.2021.10.052
  • Zhang YX, Liu HD, Chen ZH, Jin T, Hu JK, Yang K. Comparison of survival and safety between total omentectomy and partial omentectomy for gastric cancer: a meta-analysis. Front Surg. 2021;8:708545. doi:10.3389/fsurg.2021.708545
  • Ri M, Nunobe S, Honda M, et al. Gastrectomy with or without omentectomy for cT3-4 gastric cancer: a multicenter cohort study. Br J Surg. 2020;107(12):1640–1647. doi:10.1002/bjs.11702
  • Hasegawa S, Kunisaki C, Ono H, et al. Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Gastric Cancer. 2013;16(3):383–388. doi:10.1007/s10120-012-0198-6
  • Seo WJ, Choi S, Roh CK, et al. Omentum preservation as an oncologically comparable and surgically superior alternative to total omentectomy during radical gastrectomy for T3-T4 gastric cancer. Surgery. 2021;170(2):610–616. doi:10.1016/j.surg.2021.02.008
  • Young S, DiFronzo LA, Ahuja A, et al. Performing omentectomy during gastrectomy does not improve survival: a multi-center analysis of 471 patients with gastric adenocarcinoma. J Gastrointest Surg. 2020;24(12):2856–2858. doi:10.1007/s11605-020-04772-7
  • Kim DJ, Lee JH, Kim W. A comparison of total versus partial omentectomy for advanced gastric cancer in laparoscopic gastrectomy. World J Surg Oncol. 2014;12(1):64. doi:10.1186/1477-7819-12-64
  • Lee S, Suh YS, Kang SH, et al. Should total omentectomy be performed for advanced gastric cancer? The role of omentectomy during laparoscopic gastrectomy for advanced gastric cancer. Surg Endosc. 2022;36(9):6937–6948. doi:10.1007/s00464-022-09039-7
  • Lee H, Kim DJ, Lee HH, et al. Is total omentectomy mandatory in t3 and t4a gastric cancer for laparoscopic distal gastrectomy? Ann Surg Oncol. 2023;30(1):289–297. doi:10.1245/s10434-022-12386-3
  • Platell C, Cooper D, Papadimitriou JM, Hall JC. The omentum. World J Gastroenterol. 2000;6(2):169–176. doi:10.3748/wjg.v6.i2.169
  • Fujita J, Kurokawa Y, Sugimoto T, et al. Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer. 2012;15(1):42–48. doi:10.1007/s10120-011-0058-9
  • Namikawa T, Marui A, Yokota K, et al. Frequency and therapeutic strategy for patients with ovarian metastasis from gastric cancer. Langenbecks Arch Surg. 2022;407(6):2301–2308. doi:10.1007/s00423-022-02543-3
  • Kim H, Park S, Kang SY, Ahn S, Kim KM. Peritoneal seeding is more common in gastric cancer patients with FGFR2 amplification or high tumor mutation burden. Diagnostics. 2022;12(10):2355. doi:10.3390/diagnostics12102355
  • Allievi N, Bianco F, Pisano M, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience. Updates Surg. 2023;75(1):159–167. doi:10.1007/s13304-022-01399-y
  • Jongerius EJ, Boerma D, Seldenrijk KA, et al. Role of omentectomy as part of radical surgery for gastric cancer. Br J Surg. 2016;103(11):1497–1503. doi:10.1002/bjs.10149
  • Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–1820. doi:10.1056/NEJMoa072252
  • Yu J, Huang C, Sun Y, et al. Effect of laparoscopic vs open distal gastrectomy on 3-Year Disease-Free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA. 2019;321(20):1983–1992. doi:10.1001/jama.2019.5359
  • Hyung WJ, Yang HK, Park YK, et al. Long-Term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial. J Clin Oncol. 2020;38(28):3304–3313. doi:10.1200/JCO.20.01210
  • Murakami H, Yamada T, Taguri M, et al. Short-Term outcomes from a randomized screening Phase II non-inferiority trial comparing omentectomy and omentum preservation for locally advanced gastric cancer: the TOP-G trial. World J Surg. 2021;45(6):1803–1811. doi:10.1007/s00268-021-05988-7
  • Li Z, Song M, Zhou Y, et al. Efficacy of Omentum-Preserving gastrectomy for patients with gastric cancer: a systematic review and Meta-Analysis. Front Oncol. 2021;11:710814. doi:10.3389/fonc.2021.710814
  • Sato Y, Yamada T, Yoshikawa T, et al. Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC). Jpn J Clin Oncol. 2020;50(11):1321–1324. doi:10.1093/jjco/hyaa113